放疗对行化疗和手术的直肠癌患者的效果分析：一项基于SEER数据库的回顾性研究
|
|
王安君, 刘宁宁
|
Efficacy of radiotherapy in patients with rectal cancer undergoing chemotherapy and surgery: a retrospective study based on the SEER database
|
|
WANG Anjun, LIU Ningning
|
|
表4 S组和S+RT组直肠癌患者OS和CSS比较
|
Tab 4 Comparison of OS and CSS in the patients with rectal cancer between the S group and the S+RT group
|
|
| Test model | Before PSM | After PSM |
|---|
S group (95%CI) | S+RT group (95%CI) | P value | S group (95%CI) | S+RT group (95%CI) | P value |
|---|
| Log-rank | | | | | | | | Median OS/month | 62 (55‒72) | 142 (129‒155) | ‒ | 106 (88‒129) | 116 (98‒132) | ‒ | | Median CSS/month | 79 (66‒107) | NA | ‒ | NA | NA | ‒ | | RMST | | | | | | | | 60 months (5 years) survival time | 44.2 (43.0‒45.3) | 52.2 (51.5‒52.9) | 0.000 | 48.0 (46.7‒49.4) | 50.6 (49.4‒51.7) | 0.005 | 60 months (5 years) cancer specific survival time | 45.9 (44.8‒47.0) | 53.8 (53.2‒54.5) | 0.000 | 49.9 (48.7‒51.2) | 51.7 (50.6‒52.9) | 0.033 | | 120 months (10 years) survival time | 70.1 (67.3‒72.8) | 90.3 (88.5‒92.1) | 0.000 | 80.3 (77.0‒83.6) | 84.6 (81.5‒87.6) | 0.065 | 120 months (10 years) cancer specific survival time | 75.2 (72.4‒78.1) | 96.6 (94.8‒98.3) | 0.000 | 86.3 (83.0‒89.6) | 89.6 (86.6‒92.7) | 0.147 |
|
|
|